Renalytix partners with Tempus AI to expand kidney disease testing

Go back to Renalytix partners with Tempus AI to expand kidney disease testing
Oppenheimer Real Estate Fund Class N (NASDAQ: RENX) Delayed: 1.75 +0.02 (1.16%)
Previous Close $1.73    52 Week High $18.34 
Open $1.70    52 Week Low $14.92 
Day High $1.77    P/E N/A 
Day Low $1.70    EPS $0.00 
Volume 16,313       

(AMEX: RNLXY) Delayed: 1.21 +0.06 (5.22%)
Previous Close $1.15    52 Week High
Open $1.21    52 Week Low
Day High $1.21    P/E N/A 
Day Low $1.21    EPS
Volume 110       

StemCells, Inc. (NASDAQ: TEM) Delayed: 56.46 +1.59 (2.90%)
Previous Close $54.87    52 Week High $0.45 
Open $54.22    52 Week Low $0.37 
Day High $57.10    P/E N/A 
Day Low $53.37    EPS $-0.31 
Volume 4,546,682